3
Announcements
Trials
Browse
Landscape
Status
Completed
7
Recruiting
5
Unknown
3
Terminated
2
Not yet recruiting
2
Active not recruiting
2
Sponsor Class
INDUSTRY
2
Study Type
Observational
2
Interventional
2
Sponsor
Cancer Type
Thoracic
2
Conditions
Carcinoma, Non-Small-Cell Lung
2
Thoracic Neoplasms
1
Respiratory Tract Neoplasms
1
Respiratory Tract Diseases
1
Neoplasms by Site
1
Lung Neoplasms
1
Lung Diseases
1
Carcinoma, Bronchogenic
1
Bronchial Neoplasms
1
Interventions
Blood Specimen Collection
27
Surveys and Questionnaires
24
Magnetic Resonance Spectroscopy
10
Observation
7
Flow Cytometry
7
Specimen Handling
6
Amplified Fragment Length Polymorphism Analysis
6
exemestane
5
Radiotherapy
5
Magnetic Resonance Imaging
5
Immunoenzyme Techniques
5
Biopsy
5
Radiation
4
Neoadjuvant Therapy
4
Mental Status and Dementia Tests
4
Genetic Testing
4
Gene Expression Profiling
4
Electroporation
4
Data Collection
4
Bevacizumab
4
Trastuzumab
3
Tomography, X-Ray Computed
3
Tomography, Optical Coherence
3
Therapeutics
3
Surgical Procedures, Operative
3
Sunitinib
3
Sorafenib
3
Registries
3
Radiosurgery
3
Psychiatric Rehabilitation
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Terminated
×
Observational
×
Patient Reported Outcome Measures
×
Clear all
NCT03053297
2018-02-08
PANORAMA
AstraZeneca
Terminated
89 enrolled
NCT02405247
2015-07-31
TAURAS
AstraZeneca
Terminated
400 enrolled